MKI67 and diffuse large B-cell lymphoma: Core biopsy suggested poorly differentiated carcinoma, but immunohistochemistry confirmed diffuse large B‐cell lymphoma (DLBCL), activated B‐cell subtype, with high Ki‐67 (~90%).